07/30/2025
Great article by Olivia Haslam at NutraIngredients about the exciting new clinical research on Specnova’s GingerT3® ginger extract. We’re proud to have supported this study, published in Nutrients and featured in her July 24, 2025 article.
This randomized, placebo‑controlled trial highlights the power of our high‑potency, fermented, GingerT3® Extract. It delivers fast-acting results with a compact 125 mg daily dose. At Specnova, we’re driven by science, and this research reinforces why GingerT3® delivers industry‑leading performance.
Want to explore the full paper or consider formulation opportunities using GingerT3® in your product pipeline? Let’s connect.
https://www.nutraingredients-usa.com/Article/2025/07/24/low-dose-ginger-extract-from-specnova-reduces-joint-pain/
A new clinical study published in Nutrients reported that Specnova’s high-potency ginger extract, GingerT3, significantly reduced joint pain and inflammation in adults with mild musculoskeletal discomfort. The low-dose ginger supplement demonstrated anti-inflammatory and pain-relieving effects, po...